Next, CLL B-cells were treated with AA in the presence of a mixture of cytokines (IL-2, − 6, − 10, − 15, and − 21, BAFF, and APRIL) [30], and cell viability was assessed after 24 h. Here, TNFSF13B is linked to B-cell chronic lymphocytic leukemia.